Complement Genomics
Private Company
Total funding raised: $72M
Overview
Complement Genomics is a long-established, accredited DNA testing company that began with a vision to make DNA testing accessible to the public. Over two decades, it has expanded from paternity testing into diverse areas including pharmacogenetics for clinical trials, wildlife genetics, and COVID-19 testing. The company operates from its own state-of-the-art facility, the Durham Genome Centre, and is led by a small, dedicated management team focused on applying genomic expertise across multiple sectors.
Technology Platform
A versatile genomics services platform utilizing accredited laboratories for Next-Generation Sequencing (NGS), Quantitative PCR (Q-PCR), Digital PCR, genotyping, and biobanking, applied across human, animal, and plant DNA testing.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes with large direct-to-consumer genetics firms (e.g., AncestryDNA) in relationship testing, global CROs (e.g., LabCorp) in clinical trial services, and specialized labs in wildlife genetics. Its differentiation lies in its unique combination of UK legal accreditation, broad technical expertise across human/animal genetics, and ownership of an agile, accredited laboratory facility.